Pallor, Coldness of the extremities. In high dosage or for patient's sensitive to adrenaline: hypertension (with risk of cerebral haemorrhage), vasoconstriction 1 Adrenaline may cause or exacerbate hyperglycaemia, blood glucose should be monitored, particularly in diabetic patients.

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme. Adrenaline 1mg/10ml (1:10,000) solution for injection in pre-filled syringe is not recommended for intramuscular use in acute anaphylaxis. For intramuscular administration, a 1mg/ml (1:1000) solution should be used

Sympathomimetic agents: concomitant administration of other sympathomimetic agents may increase toxicity due to possible additive effects. Serotoninergic-adrenergic antidepressants: paroxysmal hypertension with the possibility of arrhythmia (inhibition of the entry of sympathomimetics into sympathetic fibres).

Selective MAO-A inhibitors, Linezolid (by extrapolation from non-selective MAO inhibitors): Risk of aggravation of pressor action. This is a 1 mL syringe. Each line measures in 0.01 increments until it reaches a total capacity of 1 mL. This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen. A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface. Therefore, I will be discussing how to read 5 different types of syringe you will encounter as a nurse, such as:

Reading a 3 mL Syringe

Tip: If you hear someone say give “10 cc” of this medication, cc is the same as mL. Therefore, 10 mL equals 10 cc. Reading a 10 mL Syringe Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie. Adaptor: this is the area where you screw on a needle (if you were giving an intramuscular injection etc.) or onto the IV hub of the patient’s IV to give a medication. This is a 3 mL syringe. Each line measures in 0.1 increments until it reaches a total capacity of 3 mL.

This medicinal product is not suitable for delivering a dose of less than 0.5 ml and should therefore not be used by the intravenous or intraosseous route, in neonates and infants with body weight less than 5 kg. This medicinal product is not appropriate to deliver a dose of less than 0.5 ml and should therefore not be used by the intravenous or intraosseous route, in neonates and infants with body weight less than 5 kg. Intravenous or intraosseous route (above 5 kg only): 0.1 ml/kg of 1:10,000 solution (10 micrograms/kg) to a maximum single dose of 10 ml of 1:10,000 solution (1 mg), repeated every 3-5 minutes until return of spontaneous circulation. Prolonged use of adrenaline can result in severe metabolic acidosis because of elevated blood concentrations of lactic acid. This is a 10 mL syringe. Each line measures in 0.5 increments until it reaches a total capacity of 10 mL.

Reading a 1 mL Syringe

This is a 5 mL syringe. Each line measures in 0.2 increments until it reaches a total capacity of 5 mL. Intravenous adrenaline should only be used by those experienced in the use and titration of vasopressors in their normal clinical practice. Patients who are given IV adrenaline require continuous monitoring of ECG, pulse oximetry and frequent blood pressure measurements as a minimum. ml of the 1:10,000 solution (1 mg) by the intravenous or intraosseous route, repeated every 3-5 minutes until return of spontaneous circulation.